Sphingolipid activator proteins (SAP) are required for epidermal permeability barrier homeostasis

被引：0
|
作者：
Doering, T
Holleran, WM
Potratz, A
Vielhaber, G
Elias, PM
Suzuki, K
Sandhoff, K
机构：
[1] Univ Bonn, Inst Organ Chem & Biochem, D-5300 Bonn, Germany
[2] Beiersdorf AG, Hamburg, Germany
[3] Univ N Carolina, Dept Neurol, Chapel Hill, NC USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 1999年 / 112卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
117
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [41] Receptor tyrosine kinase EPHA2 is required for epidermal barrier homeostasis
    Shi, B.
    Selph, T.
    Russell, K.
    Mahi, T.
    Khan, E.
    Martinez, I.
    Sinchi-Paucar, G.
    Liu, M.
    Peng, H.
    White, B. E. Perez
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S133 - S133
  • [42] Vitamin D receptor and coactivators SRC 2 and 3 regulate barrier sphingolipid production and epidermal permeability barrier formation
    Uchida, Y.
    Oda, Y.
    Moradian, S.
    Crumrine, D.
    Elias, P. M.
    Bikle, D. D.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S68 - S68
  • [43] REGULATION OF EPIDERMAL SPHINGOLIPID SYNTHESIS BY BARRIER REQUIREMENTS
    HOLLERAN, WM
    FEINGOLD, KR
    ELIAS, PM
    CLINICAL RESEARCH, 1991, 39 (01): : A53 - A53
  • [44] SPHINGOLIPIDS ARE REQUIRED FOR MAMMALIAN EPIDERMAL BARRIER FUNCTION - INHIBITION OF SPHINGOLIPID SYNTHESIS DELAYS BARRIER RECOVERY AFTER ACUTE PERTURBATION
    HOLLERAN, WM
    MAN, MQ
    WEN, NG
    MENON, GK
    ELIAS, PM
    FEINGOLD, KR
    JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (04): : 1338 - 1345
  • [45] PROCESSING OF EPIDERMAL GLUCOSYLCERAMIDES IS REQUIRED FOR OPTIMAL MAMMALIAN CUTANEOUS PERMEABILITY BARRIER FUNCTION
    HOLLERAN, WM
    TAKAGI, Y
    MENON, GK
    LEGLER, G
    FEINGOLD, KR
    ELIAS, PM
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (04): : 1656 - 1664
  • [46] Sphingolipid metabolism - Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell
    Sandhoff, K
    Kolter, T
    Van Echten-Deckert, G
    SPHINGOLIPIDS AS SIGNALING MODULATORS IN THE NERVOUS SYSTEM, 1998, 845 : 139 - 151
  • [47] ACTIVATOR PROTEINS AND TOPOLOGY OF LYSOSOMAL SPHINGOLIPID CATABOLISM
    FURST, W
    SANDHOFF, K
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1126 (01) : 1 - 16
  • [48] Genetic sphingolipid activator protein (SAP) deficiencies in human and a ''knockout'' mouse
    Fujita, N
    Suzuki, K
    Vanier, MT
    Popko, B
    Maeda, N
    Klein, A
    Sandhoff, K
    Nakayasu, H
    Suzuki, K
    JOURNAL OF NEUROCHEMISTRY, 1996, 66 : S1 - S1
  • [49] Regulation of permeability barrier homeostasis
    Feingold, Kenneth R.
    Denda, Mitsuhiro
    CLINICS IN DERMATOLOGY, 2012, 30 (03) : 263 - 268
  • [50] The regulation of permeability barrier homeostasis
    Feingold, Kenneth R.
    Schmuth, Matthias
    Elias, Peter M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1574 - 1576
12345